Crossmark

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study

Crossref DOI link: https://doi.org/10.1186/s13063-021-05949-4

Published Online: 2022-01-15

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mackenzie, Grant A. https://orcid.org/0000-0002-4994-2627
Osei, Isaac

Salaudeen, Rasheed

Secka, Ousman

D’Alessandro, Umberto

Clarke, Ed

Schmidt-Chanasit, Jonas

Licciardi, Paul V.

Nguyen, Cattram

Greenwood, Brian

Mulholland, Kim
Funding

Funding for this research was provided by:

bill and melinda gates foundation (INV006724)

united kingdom clinical research collaboration (5356358)
License Information

Text and Data Mining valid from 2022-01-15

Version of Record valid from 2022-01-15
More Information

Article History

Received: 19 August 2021

Accepted: 17 December 2021

First Online: 15 January 2022

Declarations

:

: The trial was approved by the GG/MRCG JEC (trial ethics reference 17683) and the LSHTM EC (trial ethics reference 17683). Written, informed consent to participate is obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below